Skip to content

Diffuse Bio vs Xbiome

Diffuse Bio logo

Diffuse Bio

We build generative AI for protein therapeutics

9 employees · est. 2022

VS
Xbiome logo

Xbiome

China's leading AI-driven microbiome drug development company

48 employees · est. 2017 · Cambridge, United States

Xbiome is the older company (2022 vs 2017); Xbiome is the larger of the two.

Side-by-Side Comparison

Diffuse Bio Xbiome
Founded
2022 2017 older
Headquarters
Not tracked yet Cambridge, United States
Employees
9 48 larger
Industry
Biotechnology, Pharmaceutical AI, Biotechnology, Pharmaceutical
Funding Stage
Not tracked yet Series B
Total Funding
$130.00K $210.00M
Funding Rounds
4 4
Services
AI-powered protein design, Protein binder optimization, Therapeutics advancement, Data-driven biological research Technology Platform Development, Pharmaceutical Research, Drug Pipeline Management, Collaboration with Scientific and Medical Communities
Target Customers
Biotechnology companies, Pharmaceutical industries, Research institutions, Academic labs Biotech and Pharma Companies, Healthcare Organizations, Research Institutions, Scientific Community
Taxonomy
Generative AIProtein TherapeuticsDrug DiscoveryBiopharmaceuticalsComputational BiologyTherapeutic Development +6 AI-driven Drug DevelopmentMicrobiome TherapeuticsGut Health ManagementPersonalized MedicineBioinformaticsMicrobial Technology +8
Website
diffuse.bio xbiome.com
Diffuse Bio logo

About Diffuse Bio

Diffuse Bio, founded in 2022, is a budding innovator in the fields of Biotechnology and Pharmaceutical. Their core focus is encapsulated in their slogan: "We build generative AI for protein therapeutics." This signifies their commitment to leveraging cutting-edge technology to enhance protein therap...

Xbiome logo

About Xbiome

Xbiome, established in 2017, is touted as China's leading AI-driven microbiome drug development company. As a pioneer in AI-based solutions, it aims to transform the biotechnology and pharmaceutical sectors, focusing on gut microbiome using sophisticated AI techniques. This approach to health levera...

Also comparing in this category

Comparing more than these two?

Get Diffuse Bio, Xbiome and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Diffuse Bio compare?

A PDF of Diffuse Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Diffuse Bio was founded in 2022, with 9 employees. Diffuse Bio, founded in 2022, is a budding innovator in the fields of Biotechnology and Pharmaceutical. Their core focus is encapsulated in their slogan: "We build generative AI for protein therapeuti. Xbiome was founded in 2017, based in Cambridge, United States, with 48 employees. Xbiome, established in 2017, is touted as China's leading AI-driven microbiome drug development company. As a pioneer in AI-based solutions, it aims to transform the biotechnology and pharmaceutical s.
Diffuse Bio has raised $130.00K and Xbiome $210.00M. Latest stage: Xbiome Series B.
Both work in Biotechnology and Pharmaceutical and list bioinformatics among their focus areas.

Compare Diffuse Bio with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Diffuse Bio on 8 Nov 2026, and Xbiome on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout